Oral Thin Films Market, By Product (Sublingual Film and Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, and Other Disease Indications), By Distribution Channel (Hospital Pharmacies

Oral Thin Films Market, By Product (Sublingual Film and Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, and Other Disease Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channels), and By Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Oral thin films (OTFs) are polymeric films intended to deliver therapeutic moieties in the oral cavity or through gastrointestinal absorption. OTFs are the most advanced and promising new approaches for drug delivery as it offers more flexibility and comfort. Oral thin films also allow for convenient and flexible drug delivery. Oral thin films provide quick release of an active pharmaceutical ingredient (API) when placed on the tongue. They are immediately absorbed by the oral mucosa and the active substance is directly transported into the blood. Thin film not only ensures more accurate administration of drugs but can also improve compliance owing to the intuitive nature of the dosage form and its inherent ease of administration.

Market Dynamics:

Rising demand for effective drug delivery systems due to growing burden of target diseases, advantages associated with the thin films, growing geriatric population, higher penetration of the oral thin film technology, and increase in focus on new product launches by industry players are major factors expected to boost growth of the global oral thin films market.

In June 2021, Shilpa Medicare announced the launch of a pediatric dose paracetamol oral thin film, under the brand name Molshil. The drug has been launched in strengths of 60 mg and 120 mg strengths in orange flavor. The company has also received approval for Molshil oral thin films after sufficiently complying bioequivalence requirements.

In May 2019, in a bid to provide relief to bedridden patient from gulping down several drugs on a daily basis, a Nashik-based pharmaceutical company has procured a first-of-its-kind multi-layer oral thin films (OTF) or drug strips that melt when kept on the tongue. This drug delivery method has already received approval from Central Drugs Standard Control Organisation and will be available at a similar price as the tables.

Key features of the study:

• This report provides in-depth analysis of the global oral thin films market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global oral thin films market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include C L Pharm, Cure Pharmaceutical, Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited, NAL Pharma, Viatris, LTS Lohmann Therapie-Systeme AG, IntelGenx Corp., and Aquestive Therapeutics Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global oral thin films market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral thin films market.

• Global Oral Thin Films Market, By Product:
• Sublingual Film
• Fast Dissolving Dental/Buccal Film
• Global Oral Thin Films Market, By Disease Indication:
• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Other Disease Indications
• Global Oral Thin Films Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels
• Global Oral Thin Films Market, By Geography:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Company Profiles:
• C L Pharm
• Cure Pharmaceutical
• Sunovion Pharmaceuticals Inc.
• ZIM Laboratories Limited
• NAL Pharma
• Viatris
• LTS Lohmann Therapie-Systeme AG
• IntelGenx Corp.
• Aquestive Therapeutics Inc.